Zyversa Therapeutics, Inc. (ZVSA) SEC Filings — 2024

Filings

• Zyversa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• ZyVersa Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
• ZyVersa Therapeutics Files 8-K: Material Agreement & Equity Sales — 8-K · Nov 6, 2024
• ZyVersa Therapeutics Announces Director Changes and Officer Appointments — 8-K · Oct 30, 2024
• ZyVersa Therapeutics Enters Material Definitive Agreement — 8-K · Sep 16, 2024
• ZyVersa Therapeutics Files Definitive Proxy Statement — DEF 14A · Sep 9, 2024
• Zyversa Therapeutics, Inc. 10-Q Filing — 10-Q · Aug 9, 2024
• ZyVersa Therapeutics Files 8-K with Material Agreement — 8-K · Aug 1, 2024
• ZyVersa Therapeutics Files 10-K/A Amendment — 10-K/A · May 15, 2024
• ZyVersa Therapeutics Files 8-K on Security Holder Rights — 8-K · Apr 25, 2024
• ZyVersa Therapeutics Files 8-K on Shareholder Votes & Reg FD — 8-K · Apr 17, 2024
• ZyVersa Therapeutics Files Proxy Statement Amendment — DEFA14A · Mar 27, 2024
• ZyVersa Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
• ZyVersa Therapeutics Seeks Shareholder Approval for Potential Reverse Stock Split — DEF 14A · Mar 19, 2024
• ZyVersa Therapeutics Faces Nasdaq Delisting Warning — 8-K · Mar 8, 2024
• ZyVersa Therapeutics Faces Delisting Concerns — 8-K · Mar 1, 2024
• Zyversa Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
• Zyversa Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• L1 Capital Exits ZyVersa Therapeutics Position — SC 13G/A · Feb 9, 2024
• INCON Co. Exits ZyVersa Therapeutics Stake — SC 13G/A · Jan 19, 2024